Lance's Corner

AHRQ Issues Regulatory Update

Mar 11, 2025

The Agency for Healthcare Research and Quality (AHRQ) has issued its weekly regulatory update, which can be read below.

AHRQ News Now banner updated 2023

March 11, 2025, Issue #949

 

AHRQ Stats: Trends in MRSA Rates, 2016 to 2021

While the overall rate of adult inpatient stays with a diagnosis of Methicillin-resistant Staphylococcus aureus (MRSA) decreased by nearly 11 percent between 2016 and 2021, rates of MRSA infections that occurred after admission increased by 47 percent between 2019 and 2021. (Source: AHRQ Healthcare Cost and Utilization Project Statistical Brief #315, Overview of Methicillin-Resistant Staphylococcus aureus (MRSA)-Related Inpatient Stays, 2016-2021.)

Today's Headlines:

New Interactive Data Resource Illustrates Trends in Sepsis Hospital Care

A new interactive tool from AHRQ allows researchers, policymakers and others to explore trends in hospital care for sepsis, a life-threatening condition that is among the most expensive to treat in U.S. hospitals. Sepsis caseloads in inpatient settings at nonfederal acute care hospitals increased from 1.8 million in 2016 to 2.5 million in 2021, an increase of nearly 40 percent. AHRQ’s new resource, released during Patient Safety Awareness Week 2025 and based on AHRQ’s Healthcare Cost and Utilization Project data, allows for the analysis of sepsis-related data over time in two important areas:
  • Morbidity and in-hospital mortality, including inpatient stays and emergency department utilization, readmissions, post-acute care transitions after hospitalization and in-hospital deaths.
  • Outcomes of sepsis hospitalizations, including length of stay, average hospital cost and total hospital costs by patient characteristics.
Additional data depicting state-specific utilization in sepsis hospital care will be added soon to the data visualization. Access this new data resource and other AHRQ data visualizations for information on diverse topics such as trends in ownership of healthcare practices, opioid hospitalizations and traumatic brain injuries.

AHRQ Celebrates Patient Safety Awareness Week

During Patient Safety Awareness Week 2025, AHRQ is showcasing its role as the federal agency leading support for research and initiatives to protect patients from avoidable harms. Highlights include—
Access more about AHRQ’s efforts to advance the field of patient safety, including information about diagnostic safety, safety research summaries, resources by setting, quality measures and more.

Delaying Broad-Spectrum Antibiotics Does Not Result in Worse Outcomes

Delaying delivery of broad-spectrum antibiotics does not result in worse patient outcomes, according to an AHRQ-supported article in Clinical Infectious Diseases. In a study that compared 67,046 patients who received delayed broad-spectrum therapy with 67,046 patients who received early broad-spectrum therapy, the authors found that death occurred in 8.7 percent of delayed broad-spectrum treatment cases, adverse drug events in 8.4 percent and readmission in 10.5 percent. In contrast, after early treatment, death occurred in 9.5 percent of cases, adverse drug events in 7.2 percent and readmission in 11.8 percent. These findings demonstrated that beginning therapy with narrower-spectrum antibiotics may not pose significant risks and could reduce antibiotic overexposure. Access the abstract.

Highlights From AHRQ’s Patient Safety Network

AHRQ’s Patient Safety Network (PSNet) highlights journal articles, books and tools related to patient safety. Articles featured this week include—

Review additional new publications in PSNet’s current issue, including recent cases and commentaries and AHRQ’s WebM&M (Morbidity and Mortality Rounds on the Web).

Upcoming AHRQ Webinars

New Research and Evidence From AHRQ

AHRQ in the Professional Literature

Outpatient low-dose initiation of buprenorphine for people using fentanyl. Suen LW, Chiang AY, Jones BLH, et al. JAMA Netw Open. 2025 Jan 2;8(1):e2456253. Access the abstract on PubMed®.

A perspective on the use of patient-reported experience and patient-reported outcome measures in ambulatory healthcare. Hays RD, Quigley DD. Expert Rev Pharmacoecon Outcomes Res. 2025 Jan 17. [Epub ahead of print.] Access the abstract on PubMed®.

Reducing antibiotic duration for acute otitis media: clinician, administrator, and parental insights to inform implementation of system-level interventions. Rinehart DJ, Gilbert A, O'Leary S, et al. Antimicrob Steward Healthc Epidemiol. 2025 Jan 2025;5(1):e3. Access the abstract on PubMed®.

Access to pediatric bed capacity according to social determinants of health: all beds are not created equal. Hegland TA, Day RT, Moynihan KM. J Pediatr. 2025 Mar;278:114447. Epub 2024 Dec 21. Access the abstract on PubMed®.

Hospitalization patterns for rural-residing children from 2002 to 2017. McDaniel CE, Hall M, Berry JG. Acad Pediatr. 2025 Jan-Feb;25(1):102554. Epub 2024 Aug 5. Access the abstract on PubMed®.

CT pulmonary angiogram clinical pretest probability tool: impact on emergency department utilization. Rosovsky RP, Isabelle M, Abbasi N, et al. J Am Coll Radiol. 2024 Dec;21(12):1851-61. Epub 2024 Aug 10. Access the abstract on PubMed®.

Hospital-physician integration and cardiac rehabilitation following major cardiovascular events. Thai NH, Post B, Young G, et al. JAMA Netw Open. 2025 Mar 3;8(3):e2462580. Access the abstract on PubMed®.

Trends in Medicaid take-up among eligible adults after the Affordable Care Act Medicaid Expansions: 2014-2019. Abdus S. Med Care Res Rev. 2025 Feb;82(1):100-6. Epub 2024 Sep 5. Access the abstract on PubMed®.

Contact Information
For comments or questions about AHRQ News Now, contact Bruce Seeman, (301) 427-1998 or Bruce.Seeman@ahrq.hhs.gov.

 

USDOL Issues Comprehensive Employer Guidance on Long COVID

The United States Department of Labor (USDOL) has issued a comprehensive set of resources that can be accessed below for employers on dealing with Long COVID.

Supporting Employees with Long COVID: A Guide for Employers

The “Supporting Employees with Long COVID” guide from the USDOL-funded Employer Assistance and Resource Network on Disability Inclusion (EARN) and Job Accommodation Network (JAN) addresses the basics of Long COVID, including its intersection with mental health, and common workplace supports for different symptoms.  It also explores employers’ responsibilities to provide reasonable accommodations and answers frequently asked questions about Long COVID and employment, including inquiries related to telework and leave.

Download the guide

Accommodation and Compliance: Long COVID

The Long COVID Accommodation and Compliance webpage from the USDOL-funded Job Accommodation Network (JAN) helps employers and employees understand strategies for supporting workers with Long COVID.  Topics include Long COVID in the context of disability under the Americans with Disabilities Act (ADA), specific accommodation ideas based on limitations or work-related functions, common situations and solutions, and questions to consider when identifying effective accommodations for employees with Long COVID.  Find this and other Long COVID resources from JAN, below:

Long COVID, Disability and Underserved Communities: Recommendations for Employers

The research-to-practice brief “Long COVID, Disability and Underserved Communities” synthesizes an extensive review of documents, literature and data sources, conducted by the USDOL-funded Employer Assistance and Resource Network on Disability Inclusion (EARN) on the impact of Long COVID on employment, with a focus on demographic differences.  It also outlines recommended actions organizations can take to create a supportive and inclusive workplace culture for people with Long COVID, especially those with disabilities who belong to other historically underserved groups.

Read the brief

Long COVID and Disability Accommodations in the Workplace

The policy brief “Long COVID and Disability Accommodations in the Workplace” explores Long COVID’s impact on the workforce and provides examples of policy actions different states are taking to help affected people remain at work or return when ready.  It was developed by the National Conference of State Legislatures (NCSL) as part of its involvement in USDOL’s State Exchange on Employment and Disability (SEED) initiative.

Download the policy brief

Understanding and Addressing the Workplace Challenges Related to Long COVID

The report “Understanding and Addressing the Workplace Challenges Related to Long COVID” summarizes key themes and takeaways from an ePolicyWorks national online dialogue through which members of the public were invited to share their experiences and insights regarding workplace challenges posed by Long COVID.  The dialogue took place during summer 2022 and was hosted by USDOL and its agencies in collaboration with the Centers for Disease Control and Prevention and the U.S. Surgeon General.

Download the report

Working with Long COVID

The USDOL-published “Working with Long COVID” fact sheet shares strategies for supporting workers with Long COVID, including accommodations for common symptoms and resources for further guidance and assistance with specific situations.

Download the fact sheet

COVID-19: Long-Term Symptoms

This USDOL motion graphic informs workers with Long COVID that they may be entitled to temporary or long-term supports to help them stay on the job or return to work when ready, and shares where they can find related assistance.

Watch the motion graphic

A Personal Story of Long COVID and Disability Disclosure

In the podcast “A Personal Story of Long COVID and Disability Disclosure,” Pam Bingham, senior program manager for Intuit’s Diversity, Equity and Inclusion in Tech team, shares her personal experience of navigating Long COVID symptoms at work.  The segment was produced by the USDOL-funded Partnership on Employment and Accessible Technology (PEAT) as part of its ongoing “Future of Work” podcast series.

Listen to the podcast

HHS OIG Issues Annual Report on State MFCUs

Per the notice below, the Office of the Inspector General (OIG) of the United States Department of Health and Human Services (HHS) has issued its annual report on the performance of state Medicaid Fraud Control Units (MFCUs).

Medicaid Fraud Control Units Fiscal Year 2023 Annual Report (OEI-09-24-00200) 

Medicaid Fraud Control Units (MFCUs) investigate and prosecute Medicaid provider fraud and patient abuse or neglect. OIG is the Federal agency that oversees and annually approves federal funding for MFCUs through a recertification process. This new report analyzed the statistical data on annual case outcomes—such as convictions, civil settlements and judgments, and recoveries—that the 53 MFCUs submitted for Fiscal Year 2023.  New York data is as follows:

Outcomes

  • Investigations1 - 556
  • Indicted/Charged - 9
  • Convictions - 8
  • Civil Settlements/Judgments - 28
  • Recoveries2 - $73,204,518

Resources

  • MFCU Expenditures3 - $55,964,293
  • Staff on Board4 - 257

1Investigations are defined as the total number of open investigations at the end of the fiscal year.

2Recoveries are defined as the amount of money that defendants are required to pay as a result of a settlement, judgment, or prefiling settlement in criminal and civil cases and may not reflect actual collections.  Recoveries may involve cases that include participation by other Federal and State agencies.

3MFCU and Medicaid Expenditures include both State and Federal expenditures.

4Staff on Board is defined as the total number of staff employed by the Unit at the end of the fiscal year.

Read the Full Report

View the Statistical Chart

Engage with the Interactive Map

GAO Issues Report on Medicaid Managed Care Service Denials and Appeal Outcomes

The United States Government Accountability Office (GAO) has issued a report on federal use of state data on Medicaid managed care service denials and appeal outcomes.  GAO found that federal oversight is limited because it doesn't require states to report on Medicaid managed care service denials or appeal outcomes and there has not been much progress on plans to analyze and make the data publicly available.  To read the GAO report on federal use of state data on Medicaid managed care service denials and appeal outcomes, use the first link below.  To read GAO highlights of the report on federal use of state data on Medicaid managed care service denials and appeal outcomes, use the second link below.
https://www.gao.gov/assets/d24106627.pdf  (GAO report on federal use of state data on Medicaid managed care service denials and appeal outcomes)
https://www.gao.gov/assets/d24106627_high.pdf  (GAO highlights on federal use of state data on Medicaid managed care service denials and appeal outcomes)

CMS Issues Latest Medicare Regulatory Activities Update

The Centers for Medicare and Medicaid Services (CMS) has issued its latest update on its regulatory activities in the Medicare program.  While dentistry is only minimally connected to the Medicare program, Medicare drives the majority of health care policies and insurance reimbursement policies throughout the country.  Therefore, it always pays to keep a close eye on what CMS is doing in Medicare.  To read the latest CMS update on its regulatory activities in Medicare, use the link below.
https://www.cms.gov/training-education/medicare-learning-network/newsletter/2024-03-14-mlnc